DHL Supply Chain's Life Sciences and Healthcare sector to invest US$400M to expand pharmaceutical and medical device distribution network by 27% to 12.7 million-sq-ft by end of 2022; expansion includes six new US sites with temperature controlled space

Sample article from our Logistic & Supply Chain

WESTERVILLE, Ohio , February 8, 2022 (press release) –

  • Expands network 27% to 12.7 million sq. ft. by end of 2022
  • Life Sciences & Healthcare is DHL Supply Chain’s fastest growing sector

DHL Supply Chain, the global and North American contract logistics leader within Deutsche Post DHL Group, announced its Life Sciences and Healthcare (LSHC) sector is investing upwards of $400 million to expand its pharmaceutical and medical device distribution network footprint by 27 percent this year – nearly 3 million additional square feet. With the ultimate goal of bringing critical healthcare products closer to trade partners and patients, DHL Supply Chain’s new investment includes six new U.S. sites by the end of 2022. The investment includes costs to invest in new buildings and technology, as well as the fit-out and start-up of new or expanded operations.

“This latest investment in our Life Sciences and Healthcare sector is testament to our track record and pedigree for delivering unrivalled supply chain expertise to our partners,” said Jim Saponaro, President, Life Sciences & Healthcare, DHL Supply Chain North America. “This substantial expansion will only further deepen the connections between our customers and the patients they serve by providing best-in-class end-to-end supply chain solutions.”

The expansion will grow the list of DHL Supply Chain’s LSHC sites to 34 by the end of 2022, strategically located across the U.S. including; Atlanta, GA, Cincinnati, OH, Memphis, TN, Reno, NV and Lebanon, PA. The new builds will be fully licensed with temperature controlled space that supports pharmaceutical storage requirements. The sites will also allow integrated solutions for both packaging and managed transportation.

DHL Supply Chain boasts myriad services in the life sciences and healthcare sector, including warehousing, secondary packaging, managed transportation, and end-to-end supply chain management services. In fact, LSHC is the fastest growing sector at DHL Supply Chain.

DHL Supply Chain’s LSHC sector aligns with the organization’s Accelerated Digitalization agenda to drive mass deployment of new technology – a key differentiator to other competitors. This strategy enables DHL Supply Chain to continuously increase efficiency and changes the way supply chain operations are run by concentrating on mature technologies like collaborative robotics, autonomous guided vehicles, smart wearables and augmented reality. Automation technology responds to the ongoing labor shortage challenge – not as a replacement – but rather complements our associates by supporting repetitive and strenuous tasks while improving efficiency and reducing error rates.

Learn more about DHL Supply Chain’s capabilities across the life sciences and healthcare industry here

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order logistic & supply chain coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.